148 related articles for article (PubMed ID: 6752906)
1. [The role of heparin in current therapy of thrombotic disease].
Komarnicki M
Pol Arch Med Wewn; 1982 Apr; 67(4):183-7. PubMed ID: 6752906
[No Abstract] [Full Text] [Related]
2. Molecular weight of heparin versus biologic activity. Some additional considerations.
Losito R; Losito C
Semin Thromb Hemost; 1985 Jan; 11(1):29-33. PubMed ID: 2579437
[No Abstract] [Full Text] [Related]
3. [Mechanisms of heparin resistance and their clinical significance].
Barkagan ZS; Lychev VG; Bishevskiĭ KM; Tsyvkina LP; Glazunova GA
Ter Arkh; 1982; 54(8):77-82. PubMed ID: 6753220
[No Abstract] [Full Text] [Related]
4. [The physiological inhibitors of blood coagulation. 1. Antithrombin III (AT III)].
Kase F; Pospísil J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):337-49. PubMed ID: 6194066
[TBL] [Abstract][Full Text] [Related]
5. The pharmacology of heparin prophylaxis.
MacHarg MA; Becht JL
J Am Vet Med Assoc; 1983 Jul; 183(1):129-30. PubMed ID: 6874519
[No Abstract] [Full Text] [Related]
6. Heparin, antithrombin, and abnormal clotting.
Rosenberg RD
Annu Rev Med; 1978; 29():367-78. PubMed ID: 77142
[No Abstract] [Full Text] [Related]
7. Rationale behind the development of low molecular weight heparin derivatives.
Hirsh J; Ofosu F; Buchanan M
Semin Thromb Hemost; 1985 Jan; 11(1):13-6. PubMed ID: 2579436
[TBL] [Abstract][Full Text] [Related]
8. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
Bombeli T; Raddatz-Mueller P; Fehr J
Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
[TBL] [Abstract][Full Text] [Related]
9. Activity of antithrombin III and effect of heparin on coagulation in shock.
Blauhut B; Necek S; Kramar H; Vinazzer H; Bergmann H
Thromb Res; 1980 Sep; 19(6):775-82. PubMed ID: 7466746
[No Abstract] [Full Text] [Related]
10. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
Herren T; Straub PW; Haeberli A
Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
[TBL] [Abstract][Full Text] [Related]
11. Heparin: biochemistry, therapy, and laboratory monitoring.
Triplett DA
Ther Drug Monit; 1979; 1(2):173-97. PubMed ID: 555571
[TBL] [Abstract][Full Text] [Related]
12. The role of natural coagulation inhibitors in hemostasis.
Brandt JT
Clin Lab Med; 1984 Jun; 4(2):245-84. PubMed ID: 6094091
[TBL] [Abstract][Full Text] [Related]
13. [Use of synthetic chromogenic substrates for the control of antithrombosis therapy with small doses of heparin].
Bokarew IM; Butorow WN; Gordejew PS; Kusnezow WA
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):142-9. PubMed ID: 6177595
[No Abstract] [Full Text] [Related]
14. [Thrombin time and antithrombin power of human plasma in the presence of heparin and some synthetic heparinoids].
BURSTEIN M; GUINAND A
J Physiol (Paris); 1955; 47(1):115-7. PubMed ID: 13243272
[No Abstract] [Full Text] [Related]
15. Sensitivity of the thrombin clotting time and activated partial thromboplastin time to low level of antithrombin III during heparin therapy.
Delorme MA; Inwood MJ; O'Keefe B
Clin Lab Haematol; 1990; 12(4):433-6. PubMed ID: 2081384
[TBL] [Abstract][Full Text] [Related]
16. [Antithrombin III deficiency as a risk factor in postoperative thrombosis].
Van Betsbrugge M
Acta Chir Belg; 1985; 85(5):299-302. PubMed ID: 4082851
[TBL] [Abstract][Full Text] [Related]
17. Heparin and it's clinical use.
Gormsen J; Kruse-Blinkenberg HO
Scand J Haematol Suppl; 1979; 34():52-60. PubMed ID: 384507
[No Abstract] [Full Text] [Related]
18. [The determination of heparin].
Aiach M
Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
[No Abstract] [Full Text] [Related]
19. Antithrombin III and heparin.
Barrowcliffe TW; Johnson EA; Thomas D
Br Med Bull; 1978 May; 34(2):143-50. PubMed ID: 350337
[No Abstract] [Full Text] [Related]
20. The interaction of proteases, antithrombin III, and heparin.
Downing MR
J Lab Clin Med; 1980 Jun; 95(6):777-82. PubMed ID: 6991619
[No Abstract] [Full Text] [Related]
[Next] [New Search]
